SARS-CoV-2 Vaccines and the Skin

Area of Science:

• Immunology
• Dermatology
• Vaccinology

Background:

• Record-time development of severe acute respiratory coronavirus 2 (SARS-CoV-2) vaccines represents a significant public health achievement.
• Dermatologic adverse effects have been observed during clinical trials and post-authorization surveillance of SARS-CoV-2 vaccines.
• Characterizing these skin manifestations is essential for understanding vaccine responses and ensuring patient safety.

Purpose of the Study:

• To review current and developing SARS-CoV-2 vaccine types and their properties.
• To describe the interaction between vaccines, the immune system, and potential clinical signs.
• To focus on reported dermatologic adverse effects and provide management recommendations.

Main Methods:

• Literature review of SARS-CoV-2 vaccine properties and immunologic interactions.
• Compilation and analysis of reported dermatologic adverse effects from clinical trials and post-marketing data.
• Synthesis of information on vaccine types, immune responses, and clinical manifestations.

Main Results:

• Overview of different SARS-CoV-2 vaccine technologies (e.g., mRNA, viral vector).
• Detailed description of various dermatologic adverse effects associated with SARS-CoV-2 vaccination.
• Discussion of the relationship between vaccine components, immune activation, and observed skin reactions.

Conclusions:

• Dermatologic side effects are a notable aspect of SARS-CoV-2 vaccination.
• Systematic characterization of these effects aids in vaccine safety monitoring and clinical management.
• Further research into the mechanisms underlying vaccine-induced skin reactions is warranted.